Alicja Januszewicz
Direktor/Vorstandsmitglied bei Women In The Enterprise of Science & Technology
Aktive Positionen von Alicja Januszewicz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Alicja Januszewicz
Ehemalige bekannte Positionen von Alicja Januszewicz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THESEUS PHARMACEUTICALS, INC. | Personalreferent | 16.12.2021 | 01.11.2022 |
BAXTER INTERNATIONAL INC. | Personalreferent | 01.08.2015 | 01.11.2016 |
EPIZYME, INC. | Corporate Officer/Principal | 01.01.2007 | 01.01.2013 |
ALLENA PHARMACEUTICALS, INC. | Personalreferent | 01.01.2019 | - |
Ausbildung von Alicja Januszewicz
Polish Academy of Sciences | Doctorate Degree |
Kenan-Flagler Business School | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Polen | 2 |
Operativ
Human Resources Officer | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
ALLENA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Commercial Services |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Alicja Januszewicz
- Erfahrung